Differential modulation of N-Type calcium channels by μ-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals

Journal of Cellular Physiology

Volumn 225, Issue 1, 2010, Pages 276-288

  Ortiz Miranda, Sonia I ^a   Dayanithi, Govindan ^b,c   Velázquez Marrero, Cristina ^a   Custer, Edward E ^a   Treistman, Steven N ^a,d   Lemos, José R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HÔPITAL SAINT ELOI   (France)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d Instituto de Neurobiologia   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL N TYPE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NEUROPEPTIDE; OXYTOCIN; VASOPRESSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CHAIN; CALCIUM CELL LEVEL; CALCIUM CURRENT; CELL MEMBRANE; CONTROLLED STUDY; LABELING INDEX; MALE; NERVE ENDING; NEUROHYPOPHYSIAL TERMINAL; NEUROHYPOPHYSIS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OXYTOCIN RELEASE; PREPULSE INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRANSLOCATION LINE; VASOPRESSIN RELEASE;

ANALGESICS, OPIOID; ANIMALS; ARGININE VASOPRESSIN; CALCIUM; CALCIUM CHANNELS, N-TYPE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MALE; OXYTOCIN; PATCH-CLAMP TECHNIQUES; PITUITARY GLAND, POSTERIOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 77956531735     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22263     Document Type: Article

References (64)

1. Becker PL, Singer JJ, Walsh JV, Jr., Fay FS. 1989. Regulation of calcium concentration in voltage-clamped smooth muscle cells. Science 244:211-214.
2. Ben-Barak Y, Russell JT, Whitnall MH, Ozato K, Gainer H. 1985. Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J Neurosci 5:81-97.
3. Bezzerides VJ, Ramsey IS, Kotecha S, Greka A, Clapham DE. 2004. Rapid vesicular translocation and insertion of TRP channels. Nat Cell Biol 6:709-720. (Pubitemid 39144476)
4. Bicknell RJ, Leng G, Lincoln DW, Russell JA. 1988a. Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment. J Physiol 396:297-317.
5. Bicknell RJ, Leng G, Russell JA, Dyer RG, Mansfield S, Zhao BG. 1988b. Hypothalamic opioid mechanisms controlling oxytocin neurones during parturition. Brain Res Bull 20:743-749.
6. Birnbaumer L, Qin N, Olcese R, Tareilus E, Platano D, Costantin J, Stefani E. 1998. Structures and functions of calcium channel beta subunits. J Bioenerg Biomembr 30:357-375. (Pubitemid 28436157)
7. Bogdanov Y, Brice NL, Canti C, Page KM, Li M, Volsen SG, Dolphin AC. 2000. Acidic motif responsible for plasma membrane association of the voltage-dependent calcium channel beta1b subunit. Eur J Neurosci 12:894-902.
8. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microscopy 224:213-232.
9. Bourque CW. 1998. Osmoregulation of vasopressin neurons: A synergy of intrinsic and synaptic processes. Prog Brain Res 119:59-76.
10. Brice NL, Dolphin AC. 1999. Differential plasma membrane targeting of voltage-dependent calcium channel subunits expressed in a polarized epithelial cell line. J Physiol 515:685-694.
11. Brown CH, Russell JA, Leng G. 2000. Opioid modulation of magnocellular neurosecretory cell activity. Neurosci Res 36:97-120. (Pubitemid 30072727)
12. Cazalis M, Dayanithi G, Nordmann JJ. 1987. Hormone release from isolated nerve endings of the rat neurohypophysis. J Physiol 390:55-70.
13. Chien AJ, Zhao X, Shirokov RE, Puri TS, Chang CF, Sun D, Rios E, Hosey MM. 1995. Roles of a membrane-localized beta subunit in the formation and targeting of functional L-type Ca2+ channels. J Biol Chem 270:30036-30044.
14. Chiu CS, Jensen K, Sokolova I, Wang D, Li M, Deshpande P, Davidson N, Mody I, Quick MW, Quake SR, Lester HA. 2002. Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions. J Neurosci 22:10251-10266.
15. Clarke G, Wood P, Merrick L, Lincoln DW. 1979. Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones. Nature 282:746-748. (Pubitemid 10217559)
16. Custer EE, Ortiz-Miranda S, Knott TK, Rawson R, Elvey C, Lee RH, Lemos JR. 2007. Identification of the neuropeptide content of individual rat neurohypophysial terminals. J Neurosci Methods 163:226-234.
17. Dayanithi G, Stuenkel EL, Nordmann JJ. 1992. Intracellular calcium and hormone release from nerve endings of the neurohypophysis in the presence of opioid agonists and antagonists. Exp Brain Res 90:539-545.
18. Dolphin AC. 2003a. Beta subunits of voltage-gated calcium channels. J Bioenerg Biomembr 35:599-620.
19. Dolphin AC. 2003b. G protein modulation of voltage-gated calcium channels. Pharmacol Rev 55:607-627.
20. Fowler CJ, Fraser GL. 1994. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem Int 24:401-426.
21. Gao T, Chien AJ, Hosey MM. 1999. Complexes of the alpha1C and beta subunits generate the necessary signal for membrane targeting of class C L-type calcium channels. J Biol Chem 274:2137-2144. (Pubitemid 29061368)
22. Grudt TJ, Williams JT. 1995. Opioid receptors and the regulation of ion conductances. Rev Neurosci 6:279-286.
23. Grynkiewicz G, Poenie M, Tsien RY. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
24. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100. (Pubitemid 11012976)
25. Hartman RD, Rosella-Dampman LM, Emmert SE, Summy-Long JY. 1986. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation. Endocrinology 119:1-11.
26. Hartman RD, Rosella-Dampman LM, Summy-Long JY. 1987. Endogenous opioid peptides inhibit oxytocin release in the lactating rat after dehydration and urethane. Endocrinology 121:536-543.
27. Heneghan JF, Mitra-Ganguli T, Stanish LF, Liu L, Zhao R, Rittenhouse AR. 2009. The Ca2+ channel beta subunit determines whether stimulation of Gq-coupled receptors enhances or inhibits N current. J Gen Physiol 134:369-384.
28. Herlitze S, Zhong H, Scheuer T, Catterall WA. 2001. Allosteric modulation of Ca2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Ca(v)beta subunits. Proc Natl Acad Sci USA 98:4699-4704.
29. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, Kojima I. 1999. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat Cell Biol 1:165-170. (Pubitemid 129656021)
30. Kato M, Chapman C, Bicknell RJ. 1992. Activation of kappa-opioid receptors inhibits depolarisation-evoked exocytosis but not the rise in intracellular Ca2+ in secretory nerve terminals of the neurohypophysis. Brain Res 574:138-146.
31. Kiyama H, Emson PC. 1990. Evidence for the co-expression of oxytocin and vasopressin messenger ribonucleic acids in magnocellular neurosecretory cells: Simultaneous demonstration of two neurohypophysin messenger ribonucleic acids by hybridization histochemistry. J Neuroendocrinol 2:257-259.
32. Lemos JR, Custer EE, Velázquez C, Marrero H, Dayanithi G, Ortiz-Miranda SI. 2002. Mechanisms of action of μ-opioids on CNS nerve terminals. Neuropsychiatry Cogn Neurosci 2:41-43.
33. Leng G, Mansfield S, Bicknell RJ, Brown D, Chapman C, Hollingsworth S, Ingram CD, Marsh MI, Yates JO, Dyer RG. 1987. Stress-induced disruption of parturition in the rat may be mediated by endogenous opioids. J Endocrinol 114:247-252.
34. Leng G, Mansfield S, Bicknell RJ, Blackburn RE, Brown D, Chapman C, Dyer RG, Hollingsworth S, Shibuki K, Yates JO, Way S. 1988. Endogenous opioid actions and effects of environmental disturbance on parturition and oxytocin secretion in rats. J Reprod Fertil 84:345-356.
35. Liu L, Rittenhouse AR. 2003. Arachidonic acid mediates muscarinic inhibition and enhancement of N-type Ca2+ current in sympathetic neurons. Proc Natl Acad Sci USA 100:295-300.
36. Ludwig A, Flockerzi V, Hofmann F. 1997. Regional expression and cellular localization of the alpha1 and beta subunit of high voltage-activated calcium channels in rat brain. J Neurosci 17:1339-1349. (Pubitemid 27073735)
37. Mezey E, Kiss JZ. 1991. Coexpression of vasopressin and oxytocin in hypothalamic supraoptic neurons of lactating rats. Endocrinology 129:1814-1820.
38. Mitra-Ganguli T, Vitko I, Perez-Reyes E, Rittenhouse AR. 2009. Orientation of palmitoylated CaVbeta2a relative to CaV2.2 is critical for slow pathway modulation of N-type Ca2+ current by tachykinin receptor activation. J Gen Physiol 134:385-396.
39. Nordmann JJ, Dayanithi G, Cazalis M. 1986. Do opioid peptides modulate, at the level of the nerve endings, the release of neurohypophysial hormones? Exp Brain Res 61:560-566.
40. Oiso Y, Iwasaki Y, Kondo K, Takatsuki K, Tomita A. 1988. Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis. Neuroendocrinology 48:658-662.
41. Ortiz-Miranda SI, Dayanithi G, Coccia V, Custer EE, Alphandery S, Mazuc E, Treistman S, Lemos JR. 2003. mu-Opioid receptor modulates peptide release from rat neurohypophysial terminals by inhibiting Ca(2+) influx. J Neuroendocrinol 15:888-894.
42. Ortiz-Miranda S, Dayanithi G, Custer E, Treistman SN, Lemos JR. 2005. Micro-opioid receptor preferentially inhibits oxytocin release from neurohypophysial terminals by blocking R-type Ca2+ channels. J Neuroendocrinol 17:583-590.
43. Paronis CA, Ko M, Sobczyk-Kojiro K, Mosberg HI, Woods JH. 1995. Effects of norbinaltorphimine (nBNI) and quartenary anologs of nBNI on CI-977-induced diuresis and analgesia. Soc Neurosci Abs 21:1362.
44. Pietrzykowski AZ, Martin GE, Puig SI, Knott TK, Lemos JR, Treistman SN. 2004. Alcohol tolerance in large-conductance, calcium-activated potassium channels of CNS terminals is intrinsic and includes two components: Decreased ethanol potentiation and decreased channel density. J Neurosci 24:8322-8332.
45. Pumford KM, Russell JA, Leng G. 1993. Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats. Exp Brain Res 94:237-246. (Pubitemid 23219994)
46. Rae J, Cooper K, Gates P, Watsky M. 1991. Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37:15-26.
47. Renaud LP, Allen AM, Cunningham JT, Jarvis CR, Johnston SA, Nissen R, Sullivan MJ, Van Vulpen E, Yang CR. 1992. Synaptic and neurotransmitter regulation of activity in mammalian hypothalamic magnocellular neurosecretory cells. Prog Brain Res 92:277-288.
48. Rusin KI, Giovannucci DR, Stuenkel EL, Moises HC. 1997. Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals. J Neurosci 17:6565-6574.
49. Russell JA, Leng G, Douglas AJ. 2003. The magnocellular oxytocin system, the fount of maternity: Adaptations in pregnancy. Front Neuroendocrinol 24:27-61.
50. Scott VE, De Waard M, Liu H, Gurnett CA, Venzke DP, Lennon VA, Campbell KP. 1996. Beta subunit heterogeneity in N-type Ca2+ channels. J Biol Chem 271:3207-3212.
51. Sharif-Naeini R, Ciura S, Zhang Z, Bourque CW. 2008. Contribution of TRPV channels to osmosensory transduction, thirst, and vasopressin release. Kidney Int 73:811-815.
52. Slizgi GR, Ludens JH. 1982. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine. J Pharmacol Exp Ther 220:585-591.
53. Soldo BL, Moises HC. 1998. mu-opioid receptor activation inhibits N- and P-type Ca2+ channel currents in magnocellular neurones of the rat supraoptic nucleus. J Physiol 513:787-804.
54. Stephens GJ, Page KM, Bogdanov Y, Dolphin AC. 2000. The alpha1B Ca2+ channel amino terminus contributes determinants for beta subunit-mediated voltage-dependent inactivation properties. J Physiol 525:377-390. (Pubitemid 30398368)
55. Strong JA, Fox AP, Tsien RW, Kaczmarek LK. 1987. Stimulation of protein kinase C recruits covert calcium channels in Aplysia bag cell neurons. Nature 325:714-717.
56. Summy-Long JY, Miller DS, Rosella-Dampman LM, Hartman RD, Emmert SE. 1984. A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin. Brain Res 309:362-366.
57. Tedford HW, Zamponi GW. 2006. Direct G protein modulation of Cav2 calcium channels. Pharmacol Rev 58:837-862.
58. Vance CL, Begg CM, Lee WL, Haase H, Copeland TD, McEnery MW. 1998. Differential expression and association of calcium channel alpha1B and beta subunits during rat brain ontogeny. J Biol Chem 273:14495-14502. (Pubitemid 28319171)
59. Velazquez-Marrero CM, Marrero HG, Lemos JR. 2010. Voltage-dependent κ-Opioid modulation of Calcium currents elicited by action ppotential waveforms in neurohypophysial terminals. J. Cell Phys (in press).
60. 2+ stores in isolated terminals of the Neurohypophysis. Soc for Neurosci Abst 865:29.
61. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, Dolphin AC. 2004. PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci 7:939-9946.
62. Wang G, Dayanithi G, Kim S, Hom D, Nadasdi L, Kristipati R, Ramachandran J, Stuenkel EL, Nordmann JJ, Newcomb R, Lemos JR. 1997. Role of Q-type Ca2+ channels in vasopressin secretion from neurohypophysial terminals of the rat. J Physiol 502:351-363.
63. Wang G, Dayanithi G, Newcomb R, Lemos JR. 1999. An R-type Ca(2+) current in neurohypophysial terminals preferentially regulates oxytocin secretion. J Neurosci 19:9235-9241. (Pubitemid 30228076)
64. Zhao BG, Chapman C, Bicknell RJ. 1988. Functional kappa-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis. Brain Res 462:62-66.